List view / Grid view
In a healthcare world that experiences a plethora of high-cost new therapies coming to market in parallel with price increases for existing speciality drugs, pharmaceutical companies are having to move away from traditional pricing models that are largely based on demand and what the market will bear. At the same…
4 May 2016 | By Ricardo Aitken and Michal Wielgus, IATA Consulting
Several air transport industry stakeholders and regulators have joined forces to create the Center of Excellence for Independent Validators in Pharmaceutical Logistics (CEIV Pharma) programme. This joint effort aims to effectively help reverse the current lack of standardisation, compliance and transparency currently afflicting the pharmaceutical air transport supply chain, via…
8 March 2016 | By Systech International
Global brands focus on consumer safety at Amsterdam conference...
By the end of 2018, 75% of the world’s prescription medications will be protected by legislation - this eBook explains the basic fundamentals of pharma serialisation...
15 October 2015 | By Victoria White
CPhI highlights these risks in the fourth and final section of its 2015 annual report, The Outsourcing perspective...
Maintaining the security of the supply chain for drug products is a significant responsibility to ensure the sustained availability of safe medicines...
11 June 2015 | By Victoria White
Healthcare firms have to be prepared to break with tradition and move away from employing a one-size-fits-all approach with existing suppliers...
20 April 2015 | By Ulrich Kaiser, University of Zurich / Susan Mendez, Melbourne Institute of Applied Economic and Social Research / Thomas Rønde, Copenhagen Business School / Hannes Ullrich, DIW Berlin and University of Zurich
Reference price systems for prescription drugs have found widespread use as cost containment tools. Under such regulatory regimes, patients co-pay a fraction of the difference between pharmacy retail price of the drug and a reference price. Reference prices are either externally (based on drug prices in other countries) or internally…
17 May 2011 | By GDS International
For most pharmaceuticals executives, the prospect of the patent cliff is looming large in their thoughts...
27 March 2007 | By Montanari R. and Rizzi A., Dipartimento di Ingegneria Industriale, Università degli Studi di Parma
Current trends show that the Radiofrequency Identification (RFID) technology and Electronic Product Code (EPC) are experiencing increasing diffusion. Several business applications adopting RFID are currently expected to grow strongly. Bar codes and RFID will coexist for many years, although the former is likely to progressively replace the latter in some…
